We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Algorithm Developed to Predict How and When Proteins Behave Badly

By LabMedica International staff writers
Posted on 05 Mar 2012
Scientists have developed an algorithm that can predict which regions of a protein are susceptible to exposure upon misfolding, and how mutations in the protein and alterations in the cellular environment might affect the stability of these vulnerable regions. More...


The predictions help scientists gain a better determination of protein mechanisms, and may one day help in developing treatments to fight currently lethal neurodegenerative diseases effectively.

Several neurodegenerative diseases--including Alzheimer’s and amyotrophic lateral sclerosis (ALS), recruit and transform healthy proteins to the misfolded form, and amass in large clumps that glue up the processes of the nervous system.

The investigators presented their findings at the 56th annual meeting of the Biophysical Society (BPS), held February 25-29, 2012, in San Diego, CA, USA. The algorithm developed by the researchers utilizes the energy equations of thermodynamics to calculate the likelihood that certain stretches of protein will be displayed when the protein misfolds. Since the exposed regions are specific to the misfolded version of the protein, researchers can use these areas as targets for diagnostic and therapeutic treatments. The algorithm can be modified for different proteins, and it predicts several potential target regions for each protein. The investigators have used it to study neurodegenerative disease-causing proteins as well as misfolded proteins that have been implicated in some cancers.

More recently, the researchers used computer simulations to manipulate proteins in a virtual environment, assessing out how simple it is for mutated proteins to misfold and propagate. Using this application has helped the team predict the progression of hereditary ALS disease. “The fact that we can predict the lifetime of an individual diagnosed with hereditary ALS from simulations of a protein’s mechanical properties is something that is both satisfying and that gives one pause,” said Dr. Steven Plotkin, a biophysicist at the University of British Columbia (Vancouver, Canada) who studies the process of protein misfolding. “We hope that such information might give some clues as to how to develop effective therapies for this disease.”

Related Links:
University of British Columbia
Biophysical Society Annual Meeting


New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Portable Electronic Pipette
Mini 96
Capillary Blood Collection Tube
IMPROMINI M3
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.